--- page 1 --- 1 Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange ”) and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia). This announcement does not, and is not intended to, constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States or in any other jurisdiction. The Offer Shares have not been and will not be registered under the United States Securities Act of 1933, as amended from time to time (the “U.S. Securities Act”) or securities law of any state or other jurisdiction of the United States and may not be offered, sold, pledged or otherwise transferred within the United States, except in transactions exempt from, or not subject to, the registration requirements of the U.S. Securities Act and in compliance with any applicable state securities laws. There will be no public offer of the Offer Shares in the United States. The Offer Shares are being offered and sold solely outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and applicable laws of each jurisdiction where those offers and sales occur. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential investors should read the prospectus dated January 29, 2026 (the “Prospectus ”) issued by Distinct Healthcare Holdings Limited ( 卓正醫療控股有限公 司)(the “Company ”) for detailed information about the Global Offering described below before deciding whether or not to invest in the Shares thereby being offered. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940, as amended. Unless otherwise defined in this announcement, capitalized terms used herein shall have the same meanings as those defined in the Prospectus. In connection with the Global Offering, Haitong International Securities Company Limited as stabilization manager (the “Stabilization Manager ”) (or its affiliates or any person acting for it) on behalf of the Underwriters, to the extent permitted by the applicable laws and regulatory requirements of Hong Kong or elsewhere, may make purchases, over- allocate or effect transactions in the market or otherwise take such stabilizing action(s) with a view to stabilizing or supporting the market price of the Shares at a level higher than that which might otherwise prevail for a limited period after the Listing Date. However, there is no obligation on the Stabilization Manager (or its affiliates or any person acting for it) to conduct any such stabilizing action. Such stabilizing action, if taken, (a) will be conducted at the absolute discretion of the Stabilization Manager (or its affiliates or any person acting for it) and in what the Stabilization Manager reasonably regards as the best interest of the Company, (b) may be discontinued at any time and (c) is required to be brought to an end within 30 days after the last day for lodging applications under the Hong Kong Public Offering. Potential investors should note that no stabilizing action can be taken to support the price of the Shares for longer than the stabilization period, which will begin on the Listing Date and is expected to expire on March 5, 2026, being the 30th day after the last day for lodging applications under the Hong Kong Public Offering. After this date, when no further stabilizing action may be taken, demand for the Shares, and therefore the price of the Shares, could fall. The obligations of the Hong Kong Underwriters under the Hong Kong Underwriting Agreement to subscribe for, and to procure subscribers for, the Hong Kong Offer Shares, are subject to termination by the Joint Sponsor-Overall Coordinators (for themselves and on behalf of the Underwriters) if certain events shall occur prior to 8:00 a.m. on the Listing Date. Such grounds are set out in the section headed “Underwriting ” in the Prospectus. It is important that you refer to that section for further details. --- page 2 --- 2 Distinct Healthcare Holdings Limited 卓正醫療控股有限公司 (Incorporated in the Cayman Islands with limited liability) GLOBAL OFFERING Number of Offer Shares under the Global Offering : 4,750,000 Shares (subject to the Over- allotment Option) Number of Hong Kong Offer Shares : 475,000 Shares Number of International Offer Shares : 4,275,000 Shares (subject to the Over- allotment Option) Final Offer Price : HK$59.90 per Offer Share, plus brokerage fee of 1.0%, SFC transaction levy of 0.0027%, Stock Exchange trading fee of 0.00565% and AFRC transaction levy of 0.00015% Nominal value : USD0.001 per Share Stock code : 2677 Joint Sponsors, Joint Sponsor-Overall Coordinators, Joint Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers Joint Overall Coordinators, Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers Joint Global Coordinators, Joint Bookrunners, Joint Lead Managers Joint Bookrunners, Joint Lead Managers --- page 3 --- 3 DISTINCT HEALTHCARE HOLDINGS LIMITED/ 卓正醫療控股有限公司 ANNOUNCEMENT OF FINAL OFFER PRICE AND ALLOTMENT RESULTS Unless otherwise defined herein, capitalized terms used in this announcement shall have the same meanings as those defined in the prospectus dated January 29, 2026 (the “Prospectus ”) issued by Distinct Healthcare Holdings Limited ( 卓正醫療控股有限公司 ) (the “Company ”). Warning: In view of high concentration of shareholding in a small number of Shareholders, Shareholders and prospective investors should be aware that the price of the Shares could move substantially even with a small number of Shares traded and should exercise extreme caution when dealing in the Shares. SUMMARY Company information Stock code 2677 Stock short name DISTINCT HEALTH Dealings commencement date February 6, 2026* * see note at the end of the announcement Price Information Final Offer Price HK$59.90 Offer Price Range HK$57.70 – HK$66.60 Offer Shares and Share Capital Number of Offer Shares 4,750,000 Final Number of Offer Shares in Hong Kong Public Offering 475,000 Final Number of Offer Shares in International Offering (subject to the Over-allotment Option) 4,275,000 Number of issued shares upon Listing 64,384,350 Over-allocation No. of Offer Shares over-allocated 712,500 – International Offering 712,500 Such over-allocation may be covered by exercising the Over-allotment Option or by making purchases in the secondary market at prices that do not exceed the Offer Price or through deferred delivery or a combination of these means. In the event the Over-allotment Option is exercised, an announcement will be made on the Stock Exchange ’s website. --- page 4 --- 4 Proceeds Gross proceeds (Note) HK$284.53 million Less: Estimated listing expenses payable based on the Final Offer Price HK$(75.67) million Net proceeds HK$208.86 million Note: Gross proceeds refer to the amount to which the issuer is entitled to receive. For details of the use of proceeds, please refer to the Prospectus dated January 29, 2026. ALLOTMENT RESULTS DETAILS HONG KONG PUBLIC OFFERING No. of valid applications 147,844 No. of successful applications 9,500 Subscription level 2,730.73 times Reallocation No No. of Offer Shares initially available under the Public Offer 475,000 Final no. of Offer Shares under the Public Offer 475,000 % of Offer Shares under the Public Offer to the Global Offering 10% Note: For details of the final allocation of shares to the Hong Kong Public Offering, investors can refer to www.hkeipo.hk/IPOResult to perform a search by identification number or www.hkeipo.hk/IPOResult for the full list of allottees. --- page 5 --- 5 INTERNATIONAL OFFERING No. of placees 211 Subscription Level 5.79 times No. of Offer Shares initially available under the International Offering 4,275,000 Final no. of Offer Shares under the International Offering 4,275,000 % of Offer Shares under the International Offering to the Global Offering 90% The Directors confirm that, to the best of their knowledge, information and belief, (i) none of the Offer Shares subscribed by the placees and the public have been financed directly or indirectly by the Company, any of the Directors, chief executive of the Company, controlling shareholders, substantial shareholders, existing shareholders of the Company or any of its subsidiaries or their respective close associates; and (ii) none of the placees and the public who have purchased the Offer Shares are accustomed to taking instructions from the Company, any of the Directors, chief executive of the Company, controlling shareholders, substantial shareholders, existing shareholders of the Company or any of its subsidiaries or their respective close associates in relation to the acquisition, disposal, voting or other disposition of Shares registered in his/her/its name or otherwise held by him/her/it. --- page 6 --- 6 The placees in the International offer include the following: Cornerstone Investors Investor (1) Number of Offer Shares allocated % of total number of Offer Shares (assuming the Over-allotment Option is not exercised) % of total issued share capital after the Global Offering (assuming the Over-allotment Option is not exercised) Existing shareholders or their close associates Health Vision Hong Kong Limited 727,200 15.31% 1.13% No KingMed Diagnostics (Hong Kong) Limited (ਹᏨ᜕ (ಥ) ʮ̡ ) 386,600 8.14% 0.60% No Mininglamp Technology 257,750 5.43% 0.40% No Galaxy Dynasty Limited 128,850 2.71% 0.20% No Total 1,500,400 31.59% 2.33% Notes: (1) For further details of the Cornerstone Investors, please refer to the section headed “Cornerstone Investors ” in the Prospectus. --- page 7 --- 7 Allottee with Waivers/Consents Obtained Investor Number of Offer Shares allocated % of total number of Offer Shares (assuming the Over-allotment Option is not exercised) % of total issued share capital after the Global Offering (assuming the Over-allotment Option is not exercised) Relationship Allottee with consent under paragraph 1C(1) of Appendix F1 to the Listing Rules (the “Placing Guidelines ”) in relation to allocation to a connected client (1) Guotai Junan Investments (Hong Kong) Limited 257,700 5.43% 0.40% A connected client of Haitong International Securities Company Limited Notes: (1) For details of the consent under paragraph 1C(1) of the Placing Guidelines in relation to allocation to a connected client, please refer to the section headed “Other Information ” in this announcement. Allottee who is customer(s) or client(s)/supplier(s) of the Group Investor Number of Offer Shares allocated % of total number of Offer Shares (assuming the Over-allotment Option is not exercised) of total issued share capital after the Global Offering (assuming the Over-allotment Option is not exercised) Relationship KingMed Diagnostics (Hong Kong) Limited 386,600 8.14% 0.60% A wholly owned subsidiary of a supplier of the Group --- page 8 --- 8 LOCK-UP UNDERTAKINGS Controlling Shareholders Name Number of shares held in the Company subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing (assuming the Over-allotment Option is not exercised) Last day subject to the lock-up undertakings (1) Cheuk Sing Ho (2) 11,283,000 17.52% August 5, 2028 (3) Distinct Partners I Limited (2) 2,640,250 4.10% August 5, 2027 (4) Mr. CAO Shaoshan (2) 1,000,000 1.55% February 5, 2027 (5) Nineteen Seventy-Seven (2) 867,000 1.35% February 5, 2027 (5) Proxy Shares held by H Capital IV, L.P. (2) 1,597,048 2.48% February 5, 2027 (6) Proxy Shares held by Image Frame Investment (HK) Limited (2) 2,079,683 3.23% February 5, 2027 (6) Proxy Shares held by MPC II L.P. (2) 319,096 0.50% February 5, 2027 (6) Proxy Shares held by MPC II-A L.P. (2) 35,455 0.06% February 5, 2027 (6) Subtotal 19,821,532 30.79% Notes: (1) The expiry date of the lock-up period shown in the table above is pursuant to the deeds of lock-up undertaking entered into by each of the Controlling Shareholders in favor of the Company. The lock-up requirement under the deeds of lock-up undertaking is longer than the lock-up period in the undertakings given by the Controlling Shareholders pursuant to the Hong Kong Underwriting Agreement. The Controlling Shareholders will cease to be prohibited from disposing of or transferring Shares after the indicated date. (2) Mr. Wang, Cheuk Sing Ho, the Concert Parties and Distinct Partners I Limited, through (i) the Acting- in-Concert Agreement, (ii) the Cheuk Sing Ho Agreement, (iii) the trust deed of Distinct Trust I, and (iv) the Voting Proxy Agreements, will exercise the voting rights attached to 19,821,532 Shares in aggregate immediately following completion of the Global Offering. See the sections headed “History, Reorganization and Corporate Structure ” and “Relationship with Our Controlling Shareholders ” in the Prospectus for details. (3) Pursuant to a deed of lock-up undertaking entered into by Cheuk Sing Ho in favor of the Company, 11,283,000 Shares held by Cheuk Sing Ho will be subject to a 30-month lock-up period since the Listing Date. (4) Pursuant to a deed of lock-up undertaking entered into by Distinct Partners I Limited in favor of the Company, 2,640,250 Shares held by Distinct Partners I Limited will be subject to a 18-month lock-up period since the Listing Date. (5) Pursuant to deeds of lock-up undertaking entered into by Mr. CAO Shaoshan and Nineteen Seventy-Seven in favor of the Company, 1,000,000 Shares held by Mr. CAO Shaoshan and 867,000 Shares held by Nineteen Seventy-Seven will be subject to a 12-month lock-up period since the Listing Date. (6) Pursuant to the Voting Proxy Agreements and deeds of lock-up undertaking entered into by each of the Proxy Shareholders in favor of the Company, an aggregate of 4,031,282 Proxy Shares held by the Proxy Shareholders will be subject to a 12-month lock-up period since the Listing Date. See the section headed “History, Reorganization and Corporate Structure – Voting Agreements ” in the Prospectus for details. --- page 9 --- 9 Pre-IPO Investors (as defined in the “History, Reorganization and Corporate Structure ” section of the Prospectus) Name Number of shares held in the Company subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing (assuming the Over-allotment Option is not exercised) Last day subject to the lock-up undertakings (1) MPC II, L.P. (2) 375,543 0.58% August 5, 2026 MPC II-A, L.P. (3) 41,727 0.06% August 5, 2026 Waterwood DHC Project Ltd 7,500,000 11.65% August 5, 2026 Humansa Tech (HK) Limited 1,144,200 1.78% August 5, 2026 Beijing Tiantu Xingbei Investment Center (Limited Partnership) ( ̏ԯ ˂ྡጳ̏ҳ༟ʕː (Υྫ )) 1,021,460 1.59% August 5, 2026 Chengdu Tiantu Tiantou Dongfeng Equity Investment Fund Center (Limited Partnership) ( ϓே˂ྡ˂ ʕː (Υ ྫ)) 437,770 0.68% August 5, 2026 CICC Kangrui Phase I (Ningbo) Equity Investment Fund Partnership (Limited Partnership) (ੰ๿ఠ ಂ(ت)ΥྫΆุ (Υྫ )) 1,979,610 3.07% August 5, 2026 Waterwood Tactics Limited 989,810 1.54% August 5, 2026 Qianhai Ark (BVI) Investment Co., Limited 441,527 0.69% August 5, 2026 Image Frame Investment (HK) Limited(4) 9,486,369 14.73% August 5, 2026 H Capital IV, L.P. (5) 7,284,852 11.31% August 5, 2026 H SF Investment LLC 35,100 0.05% August 5, 2026 --- page 10 --- 10 Name Number of shares held in the Company subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing (assuming the Over-allotment Option is not exercised) Last day subject to the lock-up undertakings (1) Chengdu Tianfu Qianshi Equity Investment Partnership Enterprise (Limited Partnership) (૵ ᛆҳ༟ΥྫΆุ (Υྫ )) 351,600 0.55% August 5, 2026 Chinalin Chuangxin Investment Co. Ltd. (ʮ̡ ) 351,600 0.55% August 5, 2026 Violet Gem Limited 1,019,700 1.58% August 5, 2026 Subtotal 32,460,868 50.42% Notes: (1) The expiry date of the lock-up period shown in the table above is pursuant to the deeds of lock-up undertaking entered into by each of the Pre-IPO Investors named herein in favor of the Company. (A) 1,750,000 Shares held by Tiantu Xingbei Investment Center (Limited Partnership) ( ̏ԯ˂ྡጳ̏ҳ༟ʕː (Υྫ )), (B) 750,000 Shares held by Chengdu Tiantu Dongfeng Equity Investment Fund Center (Limited Partnership) (ʕː (Υྫ )), (C) 1,080,000 Shares held by MPC II, L.P. and 120,000 Shares held by MPC II-A, L.P., and (D) the total of 492,200 Shares held by Deripi Limited, Buchkana Holdings Limited and Flarensi Holdings Limited aggregately, are not subject to any lock-up upon the Listing. (2) Excluding the 319,096 Proxy Shares held by MPC II, L.P., which are subject to a 12-month lock-up period since the Listing Date as disclosed under the section headed “Lock-up Undertakings – Controlling Shareholders ” in this announcement. See the section headed “History, Reorganization and Corporate Structure – Voting Agreements ” in the Prospectus for details. (3) Excluding the 35,455 Proxy Shares held by MPC II-A, L.P., which are subject to a 12-month lock-up period since the Listing Date as disclosed under the section headed “Lock-up Undertakings – Controlling Shareholders ” in this announcement. See the section headed “History, Reorganization and Corporate Structure – Voting Agreements ” in the Prospectus for details. (4) Excluding the 2,079,683 Proxy Shares held by Image Frame Investment (HK) Limited, which are subject to a 12-month lock-up period since the Listing Date as disclosed under the section headed “Lock-up Undertakings – Controlling Shareholders ” in this announcement. See the section headed “History, Reorganization and Corporate Structure – Voting Agreements ” in the Prospectus for details. (5) Excluding the 1,597,048 Proxy Shares held by H Capital IV, L.P., which are subject to a 12-month lock-up period since the Listing Date as disclosed under the section headed “Lock-up Undertakings – Controlling Shareholders ” in this announcement. See the section headed “History, Reorganization and Corporate Structure – Voting Agreements ” in the Prospectus for details. --- page 11 --- 11 Existing Shareholders (other than the Controlling Shareholders and the Pre-IPO Investors as defined in the “History, Reorganization and Corporate Structure ” section of the Prospectus) Name Number of shares held in the Company subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing (assuming the Over-allotment Option is not exercised) Last day subject to the lock-up undertakings (1) Shine Step International Limited 800,000 1.24% August 5, 2026 Distinct Partners II Limited 2,359,750 3.67% August 5, 2027 Subtotal 3,159,750 4.91% Note: (1) The expiry date of the lock-up period shown in the table above is pursuant to the deeds of lock-up undertaking entered into by each of the existing Shareholders named herein in favor of the Company. Cornerstone Investors Name Number of shares held in the Company subject to lock-up undertakings upon Listing % of shareholding in the Company subject to lock-up undertakings upon Listing (assuming the Over-allotment Option is not exercised) Last day subject to the lock-up undertakings (1) Health Vision Hong Kong Limited 727,200 1.13% August 5, 2026 KingMed Diagnostics (Hong Kong) Limited (ਹᏨ᜕ (ಥ)ʮ̡ ) 386,600 0.60% August 5, 2026 Mininglamp Technology 257,750 0.40% August 5, 2026 Galaxy Dynasty Limited 128,850 0.20% August 5, 2026 Subtotal 1,500,400 2.33% Note: (1) In accordance with the relevant Listing Rule/guidance materials, the required lock-up ends on August 5, 2026. The Cornerstone Investors will cease to be prohibited from disposing of or transferring Shares after the indicated date. For details, please refer to the section headed “Cornerstone Investors – Restrictions on the Cornerstone Investors ” of the Prospectus. --- page 12 --- 12 PLACEE CONCENTRATION ANALYSIS Placees Number of Shares allotted Allotment as % of International Offering (assuming no exercise of the Over-allotment Option) Allotment as % of International Offering (assuming the Over-allotment Option is fully exercised and new Shares are issued) Allotment as % of total Offer Shares (assuming no exercise of the Over-allotment Option) Allotment as % of total Offer Shares (assuming the Over-allotment Option is fully exercised and new Shares are issued) Number of Shares held upon Listing % of total issued share capital upon Listing (assuming no exercise of the Over-allotment Option) % of total issued share capital upon Listing (assuming the Over-allotment Option is fully exercised and new Shares are issued) Top 1 1,041,450 24.36% 20.88% 21.93% 19.07% 1,041,450 1.62% 1.60% Top 5 3,066,250 71.73% 61.48% 64.55% 56.13% 3,066,250 4.76% 4.71% Top 10 4,128,700 96.58% 82.78% 86.92% 75.58% 4,128,700 6.41% 6.34% Top 25 4,779,550 111.80% 95.83% 100.62% 87.50% 4,779,550 7.42% 7.34% Note * Ranking of placees is based on the number of Shares allotted to the placees. SHAREHOLDER CONCENTRATION ANALYSIS Shareholders Number of Shares allotted Allotment as % of International Offering (assuming no exercise of the Over-allotment Option) Allotment as % of International Offering (assuming the Over-allotment Option is fully exercised and new Shares are issued) Allotment as % of total Offer Shares (assuming no exercise of the Over-allotment Option) Allotment as % of total Offer Shares (assuming the Over-allotment Option is fully exercised and new Shares are issued) Number of Shares held upon Listing % of total issued share capital upon Listing (assuming no exercise of the Over-allotment Option) % of total issued share capital upon Listing (assuming the Over-allotment Option is fully exercised and new Shares are issued) Top 1 0 0.00% 0.00% 0.00% 0.00% 15,790,250 24.52% 24.26% Top 5 0 0.00% 0.00% 0.00% 0.00% 48,687,242 75.62% 74.79% Top 10 1,041,450 24.36% 20.88% 21.93% 19.07% 58,203,773 90.40% 89.41% Top 25 4,265,500 99.78% 85.52% 89.80% 78.09% 63,864,750 99.19% 98.11% Note * Ranking of Shareholders is based on the number of Shares (of all classes) held by the Shareholder upon Listing. --- page 13 --- 13 BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING Subject to the satisfaction of the conditions set out in the Prospectus, a total of 147,844 valid applications made by the public will be conditionally allocated on the basis set out below: Pool A Number of Shares applied for Number of valid applications Basis of allocation/ballot Approximate percentage allotted of the total number of Shares applied for 50 59,805 599 out of 59,805 applicants to receive 50 shares 1.00% 100 32,178 454 out of 32,178 applicants to receive 50 shares 0.71% 150 4,772 83 out of 4,772 applicants to receive 50 shares 0.58% 200 2,600 52 out of 2,600 applicants to receive 50 shares 0.50% 250 2,317 52 out of 2,317 applicants to receive 50 shares 0.45% 300 1,991 49 out of 1,991 applicants to receive 50 shares 0.41% 350 965 26 out of 965 applicants to receive 50 shares 0.38% 400 1,425 40 out of 1,425 applicants to receive 50 shares 0.35% 450 884 27 out of 884 applicants to receive 50 shares 0.34% 500 5,215 164 out of 5,215 applicants to receive 50 shares 0.31% 600 1,283 44 out of 1,283 applicants to receive 50 shares 0.29% 700 2,538 94 out of 2,538 applicants to receive 50 shares 0.26% 800 1,061 42 out of 1,061 applicants to receive 50 shares 0.25% 900 687 29 out of 687 applicants to receive 50 shares 0.23% 1,000 3,611 160 out of 3,611 applicants to receive 50 shares 0.22% 1,500 2,126 115 out of 2,126 applicants to receive 50 shares 0.18% 2,000 1,151 72 out of 1,151 applicants to receive 50 shares 0.16% 2,500 1,053 74 out of 1,053 applicants to receive 50 shares 0.14% 3,000 858 66 out of 858 applicants to receive 50 shares 0.13% 3,500 539 45 out of 539 applicants to receive 50 shares 0.12% 4,000 503 45 out of 503 applicants to receive 50 shares 0.11% 4,500 432 41 out of 432 applicants to receive 50 shares 0.11% 5,000 1,308 128 out of 1,308 applicants to receive 50 shares 0.10% 6,000 671 72 out of 671 applicants to receive 50 shares 0.09% 7,000 564 66 out of 564 applicants to receive 50 shares 0.08% 8,000 597 74 out of 597 applicants to receive 50 shares 0.08% 9,000 501 66 out of 501 applicants to receive 50 shares 0.07% 10,000 3,098 428 out of 3,098 applicants to receive 50 shares 0.07% 20,000 1,735 338 out of 1,735 applicants to receive 50 shares 0.05% 30,000 1,192 284 out of 1,192 applicants to receive 50 shares 0.04% 40,000 770 211 out of 770 applicants to receive 50 shares 0.03% 50,000 743 228 out of 743 applicants to receive 50 shares 0.03% 60,000 546 183 out of 546 applicants to receive 50 shares 0.03% 70,000 826 299 out of 826 applicants to receive 50 shares 0.03% Total 140,545 Total number of Pool A successful applicants: 4,750 --- page 14 --- 14 Pool B Approximate percentage allotted of the Number Number total number of of Shares of valid Shares applied applied for applications Basis of allocation/ballot for 80,000 2,427 1,554 out of 2,427 applicants to receive 50 shares 0.04% 90,000 522 336 out of 522 applicants to receive 50 shares 0.04% 100,000 1,415 914 out of 1,415 applicants to receive 50 shares 0.03% 150,000 1,178 773 out of 1,178 applicants to receive 50 shares 0.02% 237,500 1,757 1,173 out of 1,757 applicants to receive 50 shares 0.01% Total 7,299 Total number of Pool B successful applicants: 4,750 As of the date of this announcement, the relevant subscription monies previously deposited in the designated nominee accounts have been remitted back to the accounts of all HKSCC participants. Investors should contact their relevant brokers for any inquiries. COMPLIANCE WITH LISTING RULES AND GUIDANCE The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of which consent has been obtained, the Company has complied with the Listing Rules and guidance materials in relation to the placing, allotment and listing of the Company ’s Shares. The Directors confirm that, to the best of their knowledge, no rebate has been, directly or indirectly, provided by the Company, its controlling shareholder(s), directors or syndicate members to any placees or the public (as the case may be) and the consideration payable by them for each Offer Share of the Company subscribed for or purchased by them is the same as the Offer Price determined by the Company, in addition to any brokerage, AFRC transaction levy, SFC transaction levy and trading fee payable. OTHER INFORMATION Placing to a connected client with prior consent under paragraph 1C(1) of the Placing Guidelines The Company has applied to the Stock Exchange, and the Stock Exchange has granted, a consent under paragraph 1C(1) of the Placing Guidelines to permit the Company to allocate certain Offer Shares in the International Offering to a connected client as placees. The allocation of Offer Shares to such connected client is in compliance with all the conditions under the consent granted by the Stock Exchange. Details of the placement to connected client are set out below. --- page 15 --- 15 No. Connected distributor Connected client Relationship Whether the connected client will hold the beneficial interests of the Offer Shares on a non – discretionary basis or discretionary basis for independent third parties Number of Offer Shares to be allocated to the connected client Approximate percentage of Offer Shares allocated to the connected client (assuming the Over-Allotment Option is not exercised) Approximate percentage of total issued share capital after the Global Offering (assuming the Over-Allotment Option is not exercised) 1. Haitong International Securities Company Limited ( “HTI Securities ”) Guotai Junan Investments (Hong Kong) Limited (“GTJAI”)(1) GTJAI is a member of the same group of HTI Securities Non-discretionary basis 257,700 5.43% 0.40% Note: (1) GTJAI proposes to subscribe for and hold the Offer Shares as a placee under the International Offering on behalf of its ultimate client on a non-discretionary basis. GTJAI shall hold the Offer Shares for hedging purpose as the single underlying asset of a back-to-back total return swap transaction (the “GTHT Back-to-back TRS ”) to be entered into between GTJAI and Guotai Haitong Securities Co., Ltd. (ʮ̡ ) (the “GTHT Onshore Parent ”) in connection with a total return swap order (the “GTHT Client TRS ”) to be entered into by GTHT Onshore Parent and an ultimate client (the “GTHT Onshore Ultimate Client ”). Such GTHT Client TRS is to be fully funded by the GTHT Onshore Ultimate Client. GTJAI will hold the Offer Shares on a non-discretionary basis for the purpose of hedging the economic exposure under the GTHT Back-to-back TRS and GTHT Client TRS only. During the tenor of the GTHT Client TRS, all economic returns of the Offer Shares will be passed to the GTHT Onshore Ultimate Client and all economic losses shall be borne by the GTHT Onshore Ultimate Client, subject to the terms and conditions of the GTHT Back-to-back TRS and GTHT Client TRS, and GTJAI will not take part in any economic return or bear any economic loss in relation to the price of the Offer Shares. The GTHT Onshore Ultimate Client may request to redeem the Shares at their own discretion, upon which GTJAI shall dispose of the Offer Shares and settle the GTHT Back-to-back TRS and GTHT Client TRS in cash in accordance with the terms and conditions of the GTHT Back-to-back TRS and GTHT Client TRS documents. Due to its internal policy, GTJAI will not exercise the voting right attaching to the Offer Shares during the tenor of the GTHT Back-to-back TRS and GTHT Client TRS. --- page 16 --- 16 The GTHT Onshore Ultimate Client is Binghao Value Selected Private Securities Investment Fund (࠽ ږIt has no ultimate beneficial owner holding 30% or more of its interest. To the best knowledge of GTJAI after making all reasonable enquiries, each of the GTHT Onshore Ultimate Client and its beneficial owners is an independent third party of GTJAI, HTI Securities and the companies which are members of the same group of HTI Securities. GTJAI is not a collective investment scheme which is not authorized by the SFC nor is expected to hold the Offer Shares on behalf of such scheme. DISCLAIMERS Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the “Stock Exchange ”) and Hong Kong Securities Clearing Company Limited ( “HKSCC ”) take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. This announcement is not for release, publication, distribution, directly or indirectly, in or into the United States (including its territories and possessions, any state of the United States and the District of Columbia). This announcement does not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities mentioned herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act ”). The securities may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the U.S. Securities Act and in compliance with any applicable state securities laws, or outside the United States unless in compliance with Regulation S under the U.S. Securities Act. There will be no public offer of securities in the United States. The Offer Shares are being offered and sold outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act. This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities. This announcement is not a prospectus. Potential investors should read the Prospectus dated January 29, 2026 issued by Distinct Healthcare Holdings Limited for detailed information about the Global Offering described below before deciding whether or not to invest in the Shares thereby being offered. * Potential investors of the Offer Shares should note that the Joint Sponsors and the Joint Sponsor-Overall Coordinators (for themselves and on behalf of the Hong Kong Underwriters) shall be entitled to terminate their obligations under the Hong Kong Underwriting Agreement with immediate effect upon the occurrence of any of the events set out in the paragraph headed “Underwriting – Underwriting Arrangements and Expenses – Hong Kong Public Offering – Grounds for Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong Kong time) on the Listing Date (which is currently expected to be on February 6, 2026). --- page 17 --- 17 PUBLIC FLOAT AND FREE FLOAT Immediately after the completion of the Global Offering, 19,301,787 Shares, representing approximately 29.98% of the issued share capital of our Company (before any exercise of the Over-allotment Option) will count towards the public float. Therefore, the number of Shares held in public hands is higher than the prescribed percentage of Shares required to be held in public hands of 25% under Rule 8.08(1) of the Listing Rules, satisfying the minimum percentage requirement in compliance with Rule 8.08(1) of the Listing Rules. Each of the Cornerstone Investors, the Controlling Shareholders and certain other existing Shareholders (including Pre-IPO Investors) has agreed to a lock-up period of no less than six months following the Listing Date. For details, please refer to the section headed “Lock-up Undertakings ” of this announcement. As such, Shares held by them upon the Listing shall not be counted towards the free float of the Shares of the Company at the time of Listing. Based on the final Offer Price of HK$59.90 per Share, the Company satisfies the free float requirement under Rule 8.08A of the Listing Rules. The Directors confirm that, immediately following completion of the Global Offering: (i) the Shares will be held by at least 300 Shareholders at the time of Listing, in compliance with Rule 8.08(2) of the Listing Rules; (ii) the three largest public Shareholders will not hold more than 50% of the Shares held in public hands at the time of Listing, in compliance with Rules 8.08(3) and 8.24 of the Listing Rules; (iii) no placee will, individually, be placed more than 10% of the enlarged issued share capital of the Company immediately after the Global Offering; and (iv) there will not be any new substantial Shareholder (as defined in the Listing Rules) immediately after the Global Offering. COMMENCEMENT OF DEALINGS The Share certificates will only become valid evidence of title at 8:00 a.m. (Hong Kong time) on Friday, February 6, 2026, provided that (i) the Global Offering has become unconditional in all respects, and (ii) the right of termination described in the section headed “Underwriting { Underwriting Arrangements and Expenses { Hong Kong Underwriting Agreement { Grounds for Termination ” in the Prospectus has not been exercised. Investors who trade the Shares prior to the receipt of Share certificates or the Share certificates becoming valid evidence of title do so entirely at their own risk. --- page 18 --- 18 Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. (Hong Kong time) on Friday, February 6, 2026, it is expected that dealings in the Shares on the Stock Exchange will commence at 9:00 a.m. on Friday, February 6, 2026. The Shares will be traded in board lots of 50 Shares each and the stock code of the Shares will be 2677. By order of the Board Distinct Healthcare Holdings Limited 卓正醫療控股有限公司 WANG Zhiyuan Chairman and Executive Director Hong Kong, February 5, 2026 As of the date of this announcement, the Board comprises Mr. WANG Zhiyuan and Mr. SHI Yi as executive Directors, Mr. CAO Shaoshan, Mr. ZHANG Xiangdong, Mr. WEI Guoxing, Ms. CHEN Xiaohong and Mr. HAO Rui as non-executive Directors, and Ms. CHEN Rui, Mr. WANG Yonggang, Mr. WANG Gaofei and Dr. GAO Pingyang as proposed independent non-executive Directors.